These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2442897)

  • 1. [Clinical study of the effectiveness of mexitil in the treatment of patients with extrasystole in old and advanced age].
    Korkuschko OW; Butenko AG; Schatilo WB
    Z Gerontol; 1987; 20(3):149-53. PubMed ID: 2442897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of the antiarrhythmic action of Mexityl in ventricular disorders of the cardiac rhythm].
    Mazur NA; Liakishev AA; Podrid FD; Piotrovskiĭ VK
    Kardiologiia; 1979 Oct; 19(10):17-21. PubMed ID: 91699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1981 Oct; 21(10):59-64. PubMed ID: 6170776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
    Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic ventricular extrasystole with propafenone (Rhythmonorm)].
    Dimitrov D
    Vutr Boles; 1984; 23(4):65-9. PubMed ID: 6209861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the anti-arrhythmic effectiveness of ethacizine, ethmozine, cordarone, mexitil and ritmilen in elderly patients with ventricular extrasystole].
    Korkushko OV; Shatilo VB
    Kardiologiia; 1990 Nov; 30(11):23-5. PubMed ID: 1707997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of using a mexitil preparation in cardiac rhythm disorders].
    Dimitrov D; Dzhurdzhev A; Batalov Z
    Vutr Boles; 1981; 20(1):71-5. PubMed ID: 7245728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
    Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
    Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
    Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of oral bepridil in ventricular arrhythmias in stable coronary insufficiency].
    Rio A; Pasco A; Dupont T; Deroubaix G; Moulinie E; Rossignol B; Pellet J; Brechenmacher C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():75-8. PubMed ID: 3938263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group.
    Eur Heart J; 1986 Sep; 7(9):749-59. PubMed ID: 3533546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the effectiveness and characteristics of the action of mexitil in the treatment of extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG
    Kardiologiia; 1986 Apr; 26(4):81-3. PubMed ID: 2423740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Optimization of the use of etmozin in treating patients suffering from frequent ventricular extrasystole].
    Bugriĭ EM; Mazur NA; Pavlova TS; Dzhishambaev ED
    Ter Arkh; 1986; 58(6):62-5. PubMed ID: 2429379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiodarone (cordarone) efficiency in atrial extrasystole].
    Reĭngardene DI; Azaravichene AP
    Ter Arkh; 2004; 76(6):87-9. PubMed ID: 15332585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.